HomeGRFS • NASDAQ
Grifols SA - ADR ADR Class B
$6.68
After Hours:
$6.60
(1.20%)-0.080
Closed: Mar 28, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer
US listed security
Previous close
$6.65
Day range
$6.50 - $6.70
Year range
$5.30 - $12.15
Market cap
5.54B USD
Avg Volume
3.15M
CDP Climate Change Score
B
Financials
Income Statement
Revenue
Net income
(EUR)Dec 2023Y/Y change
Revenue
1.77B3.32%
Operating expense
463.74M5.21%
Net income
55.99M178.99%
Net profit margin
3.16170.09%
Earnings per share
EBITDA
334.62M48.68%
Effective tax rate
26.24%
Total assets
Total liabilities
(EUR)Dec 2023Y/Y change
Cash and short-term investments
646.04M11.59%
Total assets
21.44B-0.43%
Total liabilities
13.47B3.00%
Total equity
7.97B
Shares outstanding
679.09M
Price to book
0.78
Return on assets
2.60%
Return on capital
2.96%
Net change in cash
(EUR)Dec 2023Y/Y change
Net income
55.99M178.99%
Cash from operations
156.39M131.75%
Cash from investing
-141.88M1.48%
Cash from financing
46.48M-77.02%
Net change in cash
45.35M-33.70%
Free cash flow
-1.10B
About
Grifols, S.A. is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma–based products, a field in which it is the European leader and largest worldwide, the company also supplies devices, instruments, and reagents for clinical testing laboratories. Wikipedia
Founded
Nov 18, 1940
Employees
23,744
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu